Aptahem’s collaboration with the research team at Örebro University has identified a pharmacologic mechanism of action for Apta-1
Aptahem AB (publ) announce today that the collaboration with the Cardiovascular Research Centre (CVRC) at Örebro University to map the details behind Apta-1’s effects with the support from the Knowledge Foundation’s Prospect Call now has generated results that clarify one of Apta-1’s important mechanisms.A scientifically sound mechanism of action is more or less necessary to obtain a final approval from national authorities. “We have identified a pharmacologic mechanism of action for Apta-1, down to a molecular level, which should be significant to previous results in in vivo disease